Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Production and characterization of monoclonal antibodies against the recombinant nucleoprotein of Araucaria hantavirus.

Mazzarotto GA, Raboni SM, Stella V, Carstensen S, de Noronha L, Levis S, Zanluca C, Zanetti CR, Bordignon J, Duarte dos Santos CN.

J Virol Methods. 2009 Dec;162(1-2):96-100. doi: 10.1016/j.jviromet.2009.07.022. Epub 2009 Aug 3.

PMID:
19654026
2.

Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome.

Pereira SS, Moreira-Dill LS, Morais MS, Prado ND, Barros ML, Koishi AC, Mazarrotto GA, Gonçalves GM, Zuliani JP, Calderon LA, Soares AM, Pereira da Silva LH, Duarte dos Santos CN, Fernandes CF, Stabeli RG.

PLoS One. 2014 Sep 22;9(9):e108067. doi: 10.1371/journal.pone.0108067. eCollection 2014.

3.

Characterization of monoclonal antibodies against hantavirus nucleocapsid protein and their use for immunohistochemistry on rodent and human samples.

Kucinskaite-Kodze I, Petraityte-Burneikiene R, Zvirbliene A, Hjelle B, Medina RA, Gedvilaite A, Razanskiene A, Schmidt-Chanasit J, Mertens M, Padula P, Sasnauskas K, Ulrich RG.

Arch Virol. 2011 Mar;156(3):443-56. doi: 10.1007/s00705-010-0879-6. Epub 2010 Dec 16.

PMID:
21161552
4.

Novel serological tools for detection of Thottapalayam virus, a Soricomorpha-borne hantavirus.

Schlegel M, Tegshduuren E, Yoshimatsu K, Petraityte R, Sasnauskas K, Hammerschmidt B, Friedrich R, Mertens M, Groschup MH, Arai S, Endo R, Shimizu K, Koma T, Yasuda S, Ishihara C, Ulrich RG, Arikawa J, Köllner B.

Arch Virol. 2012 Nov;157(11):2179-87. doi: 10.1007/s00705-012-1405-9. Epub 2012 Jul 25.

PMID:
22828778
5.

Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

de Carvalho Nicacio C, Gonzalez Della Valle M, Padula P, Björling E, Plyusnin A, Lundkvist A.

J Virol. 2002 Jul;76(13):6669-77.

6.

Serological diagnosis with recombinant N antigen for hantavirus infection.

Yoshimatsu K, Arikawa J.

Virus Res. 2014 Jul 17;187:77-83. doi: 10.1016/j.virusres.2013.12.040. Epub 2014 Jan 31. Review.

7.
8.

Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins.

Lindkvist M, Lahti K, Lilliehöök B, Holmström A, Ahlm C, Bucht G.

Vaccine. 2007 Feb 19;25(9):1690-9. Epub 2006 Oct 11.

PMID:
17110000
9.
10.

Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques.

Klingström J, Falk KI, Lundkvist A.

Arch Virol. 2005 Jan;150(1):79-92. Epub 2004 Sep 21.

PMID:
15449139
11.

Hantaviruses: molecular biology, evolution and pathogenesis.

Khaiboullina SF, Morzunov SP, St Jeor SC.

Curr Mol Med. 2005 Dec;5(8):773-90. Review.

PMID:
16375712
12.

Hantavirus infections in Spain: analysis of sera from the general population and from patients with pneumonia, renal disease and hepatitis.

Lledó L, Klingström J, Gegúndez MI, Plyusnina A, Vapalahti O, Saz JV, Beltrán M, Sjölander KB, Vaheri A, Plyusnin A, Lundkvist A.

J Clin Virol. 2003 Aug;27(3):296-307.

PMID:
12878094
13.

[Hantavirus infections].

Stock I.

Med Monatsschr Pharm. 2008 Apr;31(4):127-36; quiz 137-8. Review. German.

PMID:
18497244
14.

Characterization of cross-reactive and serotype-specific epitopes on the nucleocapsid proteins of hantaviruses.

Tischler ND, Rosemblatt M, Valenzuela PD.

Virus Res. 2008 Jul;135(1):1-9. doi: 10.1016/j.virusres.2008.01.013. Epub 2008 Mar 14.

PMID:
18342973
15.

Prevalence of infection with hantavirus in rodent populations of central Argentina.

Suárez OV, Cueto GR, Cavia R, Gómez Villafañe IE, Bilenca DN, Edelstein A, Martínez P, Miguel S, Bellomo C, Hodara K, Padula PJ, Busch M.

Mem Inst Oswaldo Cruz. 2003 Sep;98(6):727-32. Epub 2003 Oct 29.

16.

Hantavirus infection: a review and global update.

Bi Z, Formenty PB, Roth CE.

J Infect Dev Ctries. 2008 Feb 1;2(1):3-23. Review.

17.

Hantavirus infection in Brazil: development and evaluation of an enzyme immunoassay and immunoblotting based on N recombinant protein.

Raboni SM, Levis S, Rosa ES, Bisordi I, Delfraro A, Lemos E, Correia DC, Duarte Dos Santos CN.

Diagn Microbiol Infect Dis. 2007 May;58(1):89-97. Epub 2007 Mar 26.

PMID:
17383845
18.

Fatal illness associated with a new hantavirus in Louisiana.

Khan AS, Spiropoulou CF, Morzunov S, Zaki SR, Kohn MA, Nawas SR, McFarland L, Nichol ST.

J Med Virol. 1995 Jul;46(3):281-6.

PMID:
7561804
19.

Recent approaches in hantavirus vaccine development.

Maes P, Clement J, Van Ranst M.

Expert Rev Vaccines. 2009 Jan;8(1):67-76. doi: 10.1586/14760584.8.1.67. Review.

PMID:
19093774
20.

Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein.

Lundkvist A, Vapalahti O, Plyusnin A, Sjölander KB, Niklasson B, Vaheri A.

Virus Res. 1996 Nov;45(1):29-44.

PMID:
8896239

Supplemental Content

Support Center